The seventh day publishes a list of 20 medicinal classes containing the active substance gemifloxacin, which the Technical Committee for the Control of Medicines decided to withdraw from the market and stop its circulation.
These medicines, which are antibiotics, are used to treat bacterial infections, respiratory diseases, bronchitis, pneumonia, and otitis media
The Technical Committee for the Control of Drugs at the Egyptian Medicines Authority had suspended the registration of all preparations for the antibiotic Gemifloxacin, canceled the production of all preparations containing that substance, and gave a period of 3 months for companies to adjust their conditions and withdraw all preparations from the market
Gemifloxacin